Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle Invasive Bladder Cancer (MIBC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07026864
What this trial is testing

MRI-Guided Bladder Preservation Program For Patients With Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
Clinica Universidad de Navarra, Universidad de Navarra 31
Large-scale testing (Phase 3)Not Yet RecruitingNCT07608224
What this trial is testing

HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable HER2-Expressing MIBC

Who this might be right for
Urinary Bladder Neoplasms
West China Hospital 240
Large-scale testing (Phase 3)Active Not RecruitingNCT03924895
What this trial is testing

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

Who this might be right for
Urinary Bladder Cancer, Muscle-invasive
Merck Sharp & Dohme LLC 595
Not applicableLooking for participantsNCT07602010
What this trial is testing

Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging

Who this might be right for
Bladder CancerUrothelial Carcinoma (UC)Muscle Invasive Bladder Cancer (MIBC)+1 more
Oslo University Hospital 150
Not applicableUnknownNCT05236218
What this trial is testing

To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).

Who this might be right for
Muscle Invasive Bladder CancerSurgerySexual Wellbeing+2 more
King's College London 60
Not applicableNot Yet RecruitingNCT07440901
What this trial is testing

Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy

Who this might be right for
Muscle-invasive Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Very early researchActive Not RecruitingNCT07821177
What this trial is testing

Bladder Preservation or Cystectomy for MIBC

Who this might be right for
Muscle-Invasive Bladder CarcinomaBladder CancerUrothelial Carcinoma
Dana-Farber Cancer Institute 20
Not applicableNot Yet RecruitingNCT07525349
What this trial is testing

Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder CarcinomaUrothelial Carcinoma (UC)Bladder Cancer+2 more
Assiut University 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04241185
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

Who this might be right for
Urinary Bladder Neoplasms
Merck Sharp & Dohme LLC 520
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07624201
What this trial is testing

Trastuzumab Rezetecan and Adebrelimab as Neoadjuvant Therapy for HER2-Positive Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)
Harbin Medical University 58
Testing effectiveness (Phase 2)Looking for participantsNCT05072600
What this trial is testing

Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer

Who this might be right for
Bladder CancerBladder NeoplasmsBladder Tumors+2 more
Peking University First Hospital 54
Not applicableNot Yet RecruitingNCT07735793
What this trial is testing

Radical Cystectomy in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) and Muscle Invasive Bladder Cancer (MIBC) in Korea

Who this might be right for
Urinary Bladder Neoplasms
Janssen Korea, Ltd., Korea 1
Large-scale testing (Phase 3)Active Not RecruitingNCT04660344
What this trial is testing

Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy

Who this might be right for
Muscle-invasive Bladder Cancer
Hoffmann-La Roche 761
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07639983
What this trial is testing

Multi-Omics-Based Phase Ⅱ Trial of Trastuzumab Rezetecan Plus Camrelizumab for Perioperative Therapy in HER2-Positive Muscle-Invasive Urothelial Carcinoma

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)Urinary Bladder Cancer
Sheng Tai 44
Large-scale testing (Phase 3)Active Not RecruitingNCT04658862
What this trial is testing

TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 518
Testing effectiveness (Phase 2)Ended earlyNCT03288545
What this trial is testing

Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

Who this might be right for
Carcinoma, Transitional CellUrinary Bladder NeoplasmsUrologic Neoplasms+4 more
Astellas Pharma Global Development, Inc. 348
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06957561
What this trial is testing

Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerMuscle-invasive Bladder Cancer
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04138628
What this trial is testing

Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy

Who this might be right for
Bladder CancerBladder Cancer, Metastatic
Jørgen Bjerggaard Jensen 154
Large-scale testing (Phase 3)Active Not RecruitingNCT04700124
What this trial is testing

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 808
Not applicableLooking for participantsNCT07225205
What this trial is testing

Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy

Who this might be right for
Bladder CancerMuscle Invasive Bladder Cancer (MIBC)Muscle Invasive Bladder Cancer Urothelial Carcinoma+1 more
Johns Hopkins University 130
Next Page